Each type has distinct advantages for specific clinical scenarios. The right choice depends on patient factors, site location, and clinical goals.
| Feature | Transparent Film | Non-Woven Fixation |
|---|---|---|
| Site Visibility | Excellent — fully transparent | Poor — opaque, cannot visualize |
| Breathability | High (800-1600 g/m2/24h) | Very high (2000-4000 g/m2/24h) |
| Water Resistance | Waterproof — patient can shower | Not waterproof — absorbs moisture |
| Conformability | Good on flat surfaces | Excellent on curved/mobile areas |
| Wear Duration | 5-7 days | 3-5 days |
| MARSI Risk | Higher (aggressive adhesive) | Lower (gentler adhesive) |
| Cost | Higher | Lower (~50-70% less) |
Choose Transparent Film (INS/CDC first-line):
Choose Non-Woven Fixation:
Cochrane Review (2018): CRBSI rates comparable between types. Transparent films preferred per international guidelines for site visibility — the single most important factor in early complication detection. Non-woven reduces MARSI by 42% in elderly (JWC, 2019).
Recommendation: Stock both types. Default to transparent film; switch to non-woven when skin fragility or site mobility is a concern.
References: Ullman AJ, et al. "Dressings and Securement Devices for CVCs." Cochrane, 2018. Broadhurst D, et al. "PIVC Securement Guideline." JAVA, 2019.